Dr. Peter Van Veldhuizen, MD

Dr. Peter Van Veldhuizen, MD

Save
Medical Oncology  ·  
Male  ·  
59 y/o
(10)

Accepting new patients

Dr. Peter Van Veldhuizen, MD is a medical oncology specialist in Overland Park, KS and has been practicing for 27 years. He specializes in medical oncology and urology.Read his story

Sarah Cannon Cancer Institute at Menorah Medical Center

12140 Nall Ave Ste 200

Overland Park, KS 66209
Get Directions

Insurance Accepted

  • Aetna
  • Blue Cross Blue Shield
  • Cigna
  • Coventry Health Care
  • First Health (Coventry Health Care)
  • Humana
  • MultiPlan

Background Check

Healthgrades does not collect malpractice claims information for Kansas
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Van Veldhuizen's experience treating your condition or procedure

Dr. Van Veldhuizen's Top Procedures and Conditions

Treatment Frequency
Kidney Cancer
very high
very high

Treatment Frequency

Dr. Van Veldhuizen treats Kidney Cancer more than 96% of his peers

Dr. Van Veldhuizen treats this condition more than 96% of his peers

Rating Includes other areas of care:

  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Papillary Renal Cell Carcinoma
  • Renal Cell Cancer
Urinary Disorders
very high
very high

Treatment Frequency

Dr. Van Veldhuizen treats Urinary Disorders more than 95% of his peers

Dr. Van Veldhuizen treats this condition more than 95% of his peers

Cancer
high
high

Treatment Frequency

Dr. Van Veldhuizen treats Cancer more than 85% of his peers

Dr. Van Veldhuizen treats this condition more than 85% of his peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer

Dr. Van Veldhuizen's conditions and procedures:

  • Acute Leukemia
  • Acute Myeloid Leukemia
  • Adrenal Gland Cancer
  • All Lymphoma
  • Anal and Rectal Cancer
  • Anal Disorders
  • Anemia
  • Antiphospholipid Syndrome (APS)
  • Autoimmune Diseases
  • Bladder Cancer
  • Bladder Diseases
  • Bladder Stones
  • Bleeding Disorders
  • Blood Disorders
  • Blood Disorders in Pregnancy
  • Blood in Urine (Hematuria)
  • Bone Cancer
  • Bone Disorders
  • Bone Marrow Biopsy
  • Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brain Disorders
  • Breast Cancer
  • Breast Diseases
  • Cancer
  • Central Nervous System Lymphoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chronic Kidney Diseases
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Coagulation Defects in Pregnancy and Postpartum
  • Coagulation Disorders (incl. Hemophilia)
  • Colorectal Cancer
  • Cryoglobulinemia
  • Deep Vein Thrombosis (DVT)
  • Elevated PSA (Prostate Specific Antigen)
  • Enlarged Prostate (BPH)
  • Erectile Dysfunction
  • Esophageal Cancer
  • Esophageal Diseases
  • Gallbladder and Biliary Tract Cancer
  • Gastrointestinal Diseases
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Heart Tumors, Malignant
  • HIV (Human Immunodeficiency Virus)
  • Hodgkin's Disease
  • Hydronephrosis
  • Hypercoagulable State
  • Immune Thrombocytopenic Purpura (ITP)
  • Kidney Cancer
  • Kidney Disease
  • Kidney Stones
  • Laryngeal Cancer
  • Larynx Conditions
  • Leukocytosis
  • Liver Cancer
  • Lung Cancer
  • Lung Neoplasms, Not Specified as Malignant
  • Lymph Node Biopsy or Excision
  • Lymphocytosis
  • Lymphoma, Large-Cell
  • Macroglobulinemia (incl. Waldenstrom's )
  • Mantle Cell Lymphoma
  • Marginal Zone Lymphoma
  • Maternal Anemia
  • Mediastinal Tumors, Malignant
  • Melanoma
  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Myeloproliferative Disorders
  • Neuroendocrine Tumors
  • Neutropenia
  • Nighttime Urination (Nocturia)
  • Nodular Lymphoma
  • Non-Hodgkin's Lymphoma
  • Oral Cancer
  • Osteosarcoma
  • Ovarian Cancer
  • Painful Urination (Dysuria)
  • Pancreatic Cancer
  • Pancytopenia
  • Penile Cancer
  • Polycythemia Rubra Vera
  • Pregnancy-Related Disorders
  • Primary Central Nervous System Lymphoma
  • Primary Hypercoagulable State (incl. Factor V Leiden Disease)
  • Prostate Cancer
  • Pulmonary Disease
  • Purpura
  • Reticulosarcoma
  • Retina Diseases
  • Secondary Malignancies
  • Sexually Transmitted Diseases (STDs)
  • Sickle Cell Disease
  • Skin Cancer
  • Sleep Disorders
  • Small Intestine Cancer
  • Soft Tissue Sarcoma
  • Squamous Cell Carcinoma
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Diseases
  • Testicular Cancer
  • Testicular Dysfunction
  • Thalassemia
  • Thoracentesis
  • Thrombocytosis
  • Thrombosis
  • Thymomas
  • Thyroid Cancer
  • Tongue Cancer
  • Tonsil Cancer
  • Ureteral Stricture or Kinking
  • Urethral Stricture
  • Urinary Disorders
  • Urinary Stones
  • Urinary Tract Infection (UTI)
  • Uterine Cancer
  • Uterine Diseases
  • Vascular Disease
  • Venous Embolism and Thrombosis
  • Vertebral Column Tumors
  • Vesicoureteral Reflux
  • von Willebrand Disease
  • Yeast Infections

About Me

Biography

Dr. Peter J. Van Veldhuizen, MD, is a board-certified, fellowship trained hematology/medical oncology physician serving patients in the Greater Kansas City region. Dr. Van Veldhuizen specializes in Genitourinary (GU) malignancies and sees patients a...

Specialties

  • Medical Oncology
  • Urology

Board Certifications

  • Hematology
  • Internal Medicine
  • Medical Oncology

Education

1992
University Ks
Fellowship Hospital
1989
University Ks
Residency Hospital
1987
University Ks
Internship Hospital
1986
Sanford School Of Medicine Of The University Of South Dakota
Medical School
1992
1989
1987
1986

Languages

  • Spanish
  • English

Awards

Dr. Van Veldhuizen's Reviews

Likelihood to recommend Dr. Van Veldhuizen

5.0

Based on 10 reviews

5 Stars
100%
(10)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
0%
(0)

Leave a review

How likely are you to recommend
Dr. Van Veldhuizen?
(Select your rating)
Average Reported Wait Time
  • 10 – 15 minutes
Dr. Van Veldhuizen's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness
What People Say About Dr. Peter Van Veldhuizen, MD
Reply
There is not a better GU Oncologist in the country when it comes to renal cell Cancer. Thank you Dr. Van! You are the BEST!!!!!!!!!!!!!!
Was this helpful?
thumbs up icon option9
thumbs down icon option
×Post a ResponseAre you Dr. Peter Van Veldhuizen, MD?
Reply
Dr. Van is exceptionally patient, accessible, and determined. The hospital goes above and beyond, and he and Jennifer and Kathy take it even further. He is someone you can trust with your life.
Was this helpful?
thumbs up icon option13
thumbs down icon option1
×Post a ResponseAre you Dr. Peter Van Veldhuizen, MD?

Leave a review

How was your experience with Dr. Van Veldhuizen?

Locations

Insurance accepted

Accepted insurance can change. Please double-check when making an appointment.

Aetna
Aetna HMO
Choice Plus POS II
Blue Cross Blue Shield
Blue Card PPO
Cigna
Cigna PPO
Coventry Health Care
First Health (Coventry Health Care)
First Health (Coventry Health Care) PPO
Humana
Choice Care PPO
Preferred PPO
MultiPlan
MultiPlan PPO
PHCS Network PPO

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Van Veldhuizen treats patients.

Learn more

Menorah Medical Center

Overland Park, KS

Compare Providers

More providers like Dr. Van Veldhuizen at Sarah Cannon Cancer Institute at Menorah Medical Center

Show All Oncologists